Literature DB >> 10845680

Fatal fulminant hepatic failure associated with benzbromarone.

H Wagayama, K Shiraki, K Sugimoto, K Fujikawa, A Shimizu, K Takase, T Nakano, Y Tameda.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10845680     DOI： 10.1016/s0168-8278(00)80263-9

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  10 in total

Review 1.  Gout in solid organ transplantation: a challenging clinical problem.

Authors:  Lisa Stamp; Martin Searle; John O'Donnell; Peter Chapman
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 2.  The challenges of gout management in the elderly.

Authors:  Lisa K Stamp; Sarah Jordan
Journal:  Drugs Aging       Date:  2011-08-01       Impact factor: 3.923

3.  Autoimmune hepatitis following drug-induced liver injury in an elderly patient.

Authors:  Junichiro Kumagai; Tatsuo Kanda; Shin Yasui; Yuki Haga; Reina Sasaki; Masato Nakamura; Shuang Wu; Shingo Nakamoto; Makoto Arai; Yotaro Iino; Osamu Yokosuka
Journal:  Clin J Gastroenterol       Date:  2016-05-12

4.  Biochemical effectiveness of allopurinol and allopurinol-probenecid in previously benzbromarone-treated gout patients.

Authors:  Mattheus K Reinders; Eric N van Roon; Pieternella M Houtman; Jacobus R B J Brouwers; Tim L Th A Jansen
Journal:  Clin Rheumatol       Date:  2007-02-17       Impact factor: 2.980

Review 5.  EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).

Authors:  W Zhang; M Doherty; T Bardin; E Pascual; V Barskova; P Conaghan; J Gerster; J Jacobs; B Leeb; F Lioté; G McCarthy; P Netter; G Nuki; F Perez-Ruiz; A Pignone; J Pimentão; L Punzi; E Roddy; T Uhlig; I Zimmermann-Gòrska
Journal:  Ann Rheum Dis       Date:  2006-05-17       Impact factor: 19.103

Review 6.  A benefit-risk assessment of benzbromarone in the treatment of gout. Was its withdrawal from the market in the best interest of patients?

Authors:  Ming-Han H Lee; Garry G Graham; Kenneth M Williams; Richard O Day
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

7.  Modeling the Bioactivation and Subsequent Reactivity of Drugs.

Authors:  Tyler B Hughes; Noah Flynn; Na Le Dang; S Joshua Swamidass
Journal:  Chem Res Toxicol       Date:  2021-01-26       Impact factor: 3.739

8.  Effect of Urate-Lowering Therapy on All-Cause and Cardiovascular Mortality in Hyperuricemic Patients without Gout: A Case-Matched Cohort Study.

Authors:  Jiunn-Horng Chen; Joung-Liang Lan; Chi-Fung Cheng; Wen-Miin Liang; Hsiao-Yi Lin; Gregory J Tsay; Wen-Ting Yeh; Wen-Harn Pan
Journal:  PLoS One       Date:  2015-12-18       Impact factor: 3.240

9.  Successful Management of Acute Liver Failure Patients Waiting for Liver Transplantation by On-Line Hemodiafiltration with an Arteriovenous Fistula.

Authors:  Yuki Haga; Shin Yasui; Tatsuo Kanda; Noriyuki Hattori; Toru Wakamatsu; Masato Nakamura; Reina Sasaki; Shuang Wu; Shingo Nakamoto; Makoto Arai; Hitoshi Maruyama; Masayuki Ohtsuka; Shigeto Oda; Masaru Miyazaki; Osamu Yokosuka
Journal:  Case Rep Gastroenterol       Date:  2016-05-19

10.  Benzbromarone as a possible cause of acute kidney injury in patients with urolithiasis: Two case reports.

Authors:  Xiaolan Ye; Jian Wu; Kun Tang; Wenge Li; Cunquan Xiong; Li Zhuo
Journal:  Medicine (Baltimore)       Date:  2019-04       Impact factor: 1.817
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.